Clínica Baviera, S.A. (CBAV.MC)
EUR 36.4
(1.11%)
EUR 36.4
(1.11%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 178.64 Million EUR | 19.01% |
| 2022 | 150.1 Million EUR | 12.18% |
| 2021 | 133.8 Million EUR | 10.66% |
| 2020 | 120.92 Million EUR | 19.06% |
| 2019 | 101.56 Million EUR | 81.92% |
| 2018 | 55.83 Million EUR | 3.4% |
| 2017 | 53.99 Million EUR | 15.45% |
| 2016 | 46.76 Million EUR | 0.84% |
| 2015 | 46.37 Million EUR | -5.42% |
| 2014 | 49.03 Million EUR | 1.57% |
| 2013 | 48.27 Million EUR | -6.56% |
| 2012 | 51.66 Million EUR | -10.7% |
| 2011 | 57.85 Million EUR | 1.78% |
| 2010 | 56.84 Million EUR | -3.25% |
| 2009 | 58.75 Million EUR | -8.37% |
| 2008 | 64.11 Million EUR | 41.71% |
| 2007 | 45.24 Million EUR | 4.28% |
| 2006 | 43.39 Million EUR | 44.1% |
| 2005 | 30.11 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 193.94 Million EUR | 8.57% |
| 2024 Q2 | 203.01 Million EUR | 4.68% |
| 2023 Q4 | 178.64 Million EUR | 1.99% |
| 2023 Q2 | 170.19 Million EUR | -2.57% |
| 2023 Q1 | 174.67 Million EUR | 17.17% |
| 2023 Q3 | 175.16 Million EUR | 2.92% |
| 2023 FY | 178.64 Million EUR | 19.01% |
| 2022 Q2 | 142.35 Million EUR | 0.1% |
| 2022 Q1 | 142.21 Million EUR | 6.28% |
| 2022 FY | 150.1 Million EUR | 12.18% |
| 2022 Q4 | 149.08 Million EUR | 4.0% |
| 2022 Q3 | 143.35 Million EUR | 0.7% |
| 2021 Q1 | 129.51 Million EUR | 7.1% |
| 2021 Q3 | 130.91 Million EUR | 2.54% |
| 2021 Q4 | 133.8 Million EUR | 2.21% |
| 2021 Q2 | 127.67 Million EUR | -1.42% |
| 2021 FY | 133.8 Million EUR | 10.66% |
| 2020 Q1 | 109.78 Million EUR | 8.09% |
| 2020 Q2 | 109.22 Million EUR | -0.51% |
| 2020 Q3 | 113.62 Million EUR | 4.03% |
| 2020 Q4 | 120.92 Million EUR | 6.42% |
| 2020 FY | 120.92 Million EUR | 19.06% |
| 2019 Q2 | 95.41 Million EUR | 0.61% |
| 2019 FY | 101.56 Million EUR | 81.92% |
| 2019 Q3 | 97.31 Million EUR | 1.98% |
| 2019 Q4 | 101.56 Million EUR | 4.37% |
| 2019 Q1 | 94.83 Million EUR | 69.86% |
| 2018 Q2 | 54.17 Million EUR | 0.0% |
| 2018 Q4 | 55.83 Million EUR | 2.5% |
| 2018 FY | 55.83 Million EUR | 3.4% |
| 2018 Q3 | 54.47 Million EUR | 0.55% |
| 2017 Q4 | 53.99 Million EUR | 0.0% |
| 2017 FY | 53.99 Million EUR | 15.45% |
| 2017 Q2 | 49.32 Million EUR | 1.29% |
| 2017 Q1 | 48.69 Million EUR | 4.12% |
| 2016 Q4 | 46.76 Million EUR | 0.0% |
| 2016 Q2 | 49.7 Million EUR | 0.0% |
| 2016 FY | 46.76 Million EUR | 0.84% |
| 2015 FY | 46.37 Million EUR | -5.42% |
| 2015 Q2 | 47.55 Million EUR | 0.0% |
| 2015 Q4 | 46.37 Million EUR | 0.0% |
| 2014 Q2 | 46.66 Million EUR | 0.0% |
| 2014 FY | 49.03 Million EUR | 1.57% |
| 2014 Q4 | 49.03 Million EUR | 0.0% |
| 2013 Q4 | 48.27 Million EUR | 0.0% |
| 2013 Q2 | 49.6 Million EUR | 0.0% |
| 2013 FY | 48.27 Million EUR | -6.56% |
| 2012 FY | 51.66 Million EUR | -10.7% |
| 2012 Q2 | 56.76 Million EUR | 0.0% |
| 2012 Q4 | 51.66 Million EUR | 0.0% |
| 2011 FY | 57.85 Million EUR | 1.78% |
| 2011 Q2 | 58.83 Million EUR | 0.0% |
| 2011 Q4 | 57.85 Million EUR | 0.0% |
| 2010 Q2 | 59.9 Million EUR | 0.0% |
| 2010 FY | 56.84 Million EUR | -3.25% |
| 2010 Q4 | 56.84 Million EUR | 0.0% |
| 2009 FY | 58.75 Million EUR | -8.37% |
| 2009 Q4 | 58.75 Million EUR | 0.0% |
| 2008 FY | 64.11 Million EUR | 41.71% |
| 2007 FY | 45.24 Million EUR | 4.28% |
| 2006 FY | 43.39 Million EUR | 44.1% |
| 2005 FY | 30.11 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pangaea Oncology, S.A. | 28.83 Million EUR | -519.553% |